Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Assets Average (2020 - 2022)

Historic Assets Average for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $690.5 million.

  • Atea Pharmaceuticals' Assets Average fell 1948.24% to $690.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $690.5 million, marking a year-over-year decrease of 1948.24%. This contributed to the annual value of $818.3 million for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q3 2022, Atea Pharmaceuticals' Assets Average is $690.5 million, which was down 1948.24% from $705.8 million recorded in Q2 2022.
  • Atea Pharmaceuticals' Assets Average's 5-year high stood at $857.5 million during Q3 2021, with a 5-year trough of $486.9 million in Q4 2020.
  • Over the past 3 years, Atea Pharmaceuticals' median Assets Average value was $776.6 million (recorded in 2021), while the average stood at $750.3 million.
  • As far as peak fluctuations go, Atea Pharmaceuticals' Assets Average soared by 6599.91% in 2021, and later tumbled by 1948.24% in 2022.
  • Quarter analysis of 3 years shows Atea Pharmaceuticals' Assets Average stood at $486.9 million in 2020, then skyrocketed by 66.0% to $808.2 million in 2021, then fell by 14.57% to $690.5 million in 2022.
  • Its last three reported values are $690.5 million in Q3 2022, $705.8 million for Q2 2022, and $745.0 million during Q1 2022.